Drug intelligence / Profile preview

Co-biotic

Development stage
Unknown
Lead developer
Reitzer Healthcare
Modality
Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Oral
01

Overview

The name 'Co-biotic' is non-specific and refers to several different products, primarily probiotic dietary supplements, but also a pharmaceutical combination drug and a broader scientific concept. As a dietary supplement, 'Co-biotic' typically refers to products containing one or more strains of beneficial microorganisms, such as Saccharomyces boulardii, Lactobacillus acidophilus, and Lactobacillus bifidus. These supplements are generally used to support intestinal microflora balance, prevent antibiotic-associated diarrhea, and manage conditions like thrush (Candida albicans). The mechanism involves colonizing the intestinal tract, competing with harmful organisms, and modulating the immune response. Some products named 'Co-biotic' are single-strain, while others are multi-strain combinations. Separately, 'Cobiotic LB' is a pharmaceutical drug combining antibiotics (Amoxycillin, Cloxacillin) with Lactobacillus to treat bacterial infections. The term 'co-biotics' also refers to a scientific concept of bioactive compounds that modulate both host and microbiota.

Brand names
Co-BioticCobiotic
Other names
probiotic supplementnutritional supplement

Beyond the preview

Go deeper on Co-biotic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Co-biotic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call